गैस्ट्रोएंटरोलॉजी और पाचन रोग जर्नल

अमूर्त

Brief Note On an Oral antibiotic within the treatment of primary sclerosing cholangitis-associated pouchitis

Prathyusha.K

The combination of atezolizumab and bevacizumab showed encouraging anticancer activity and safety in a very section 1b trial involving patients with unresectable hepatoma.Pouchitis may be a common complication in those with restorative proctocolectomy with ileal pouch?anal conjugation (IPAA). Some patients might develop chronic antibiotic-refractory pouchitis and its management is difficult. Primary sclerosing rubor (PSC) has systematically been rumored to be a risk issue for chronic pouchitis.

अस्वीकृति: इस सारांश का अनुवाद कृत्रिम बुद्धिमत्ता उपकरणों का उपयोग करके किया गया है और इसे अभी तक समीक्षा या सत्यापित नहीं किया गया है।